Efficacy Study of CYT997 in Multiple Myeloma

NCT00664378 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty enrolling patients

Conditions

Relapsed and Refractory Multiple Myeloma

Interventions

DRUG: CYT997

Sponsor

Gilead Sciences